美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Accustem Sciences Inc.

0.4400

-0.0302-6.43%

成交量：1.25万

成交额：5,620.03

市值：707.18万

市盈率：- -

高：0.4500

开：0.4500

低：0.4400

收：0.4703

52周最高：2.33

52周最低：0.2450

股本：1,607.23万

流通股本：992.21万

量比：6.62

换手率：0.13%

股息：- -

股息率：- -

净资产收益率：-1794.16%

总资产收益率：-120.29%

市净率：-2.43

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

Accustem Sciences Inc.

交易所：

OTCQB

成立时间：

2013

员工人数：

2

公司地址：

5 Penn Plaza,19th Floor,#1954,New York,New York,United States

官网：

- -

邮编：

10001

电话：

- -

传真：

- -

简介：

AccuStem Sciences, Inc.于2021年7月28日在美国特拉华州成立。该公司是一家临床阶段诊断公司，致力于改善全球每年1800多万癌症患者的生活质量和预后。该公司的计划是开发一套新的基因组测试并将其商业化，以支持整个肿瘤治疗过程中的决策。该公司的重点将是将该公司的专有基因组测试StemPrintER用于早期乳腺癌患者的商业化。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/ACUT/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ACUT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACUT\",,,,,undefined,":{"symbol":"ACUT","market":"US","secType":"STK","nameCN":"Accustem Sciences Inc.","latestPrice":0.44,"timestamp":1771966800000,"preClose":0.47025,"halted":0,"volume":12504,"delay":15,"changeRate":-0.06432748538011696,"floatShares":9922079,"shares":16072267,"eps":0,"marketStatus":"未开盘","change":-0.03025,"latestTime":"02-24 16:00:00 EST 延时","open":0.45,"high":0.45,"low":0.44,"amount":5620.030000000001,"amplitude":0.021265,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1772010000000},"marketStatusCode":0,"adr":0,"exchange":"OTCQB","adjPreClose":0.47025,"volumeRatio":6.620076},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACUT\",,,,,undefined,":{"symbol":"ACUT","floatShares":9922079,"roa":"-120.29%","roe":"-1794.16%","lyrEps":0,"volumeRatio":6.620076,"shares":16072267,"dividePrice":0,"high":0.45,"amplitude":0.021265,"preClose":0.47025,"low":0.44,"week52Low":0.245,"pbRate":"-2.43","week52High":2.33,"institutionHeld":0,"latestPrice":0.44,"eps":0,"divideRate":0,"volume":12504,"delay":15,"open":0.45,"prevYearClose":0.81351,"prevWeekClose":0.4703,"prevMonthClose":0.6,"prevQuarterClose":0.8135,"fiveDayClose":0.5137,"twentyDayClose":0.6,"sixtyDayClose":0.8256},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACUT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-09-16","symbol":"ACUT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1726459200000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-05-20","symbol":"ACUT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1716177600000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACUT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ACUT\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":669855648,"yearFounded":2013,"employeeNum":2,"address":"5 Penn Plaza,19th Floor,#1954,New York,New York,United States","zipCode":"10001"},"stockCompanyDetail":{"description":"AccuStem Sciences, Inc.于2021年7月28日在美国特拉华州成立。该公司是一家临床阶段诊断公司，致力于改善全球每年1800多万癌症患者的生活质量和预后。该公司的计划是开发一套新的基因组测试并将其商业化，以支持整个肿瘤治疗过程中的决策。该公司的重点将是将该公司的专有基因组测试StemPrintER用于早期乳腺癌患者的商业化。","exchange":"OTCQB","name":"Accustem Sciences Inc.","nameEN":"Accustem Sciences Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ACUT\",market:\"US\",,,undefined,":null}}